AFTER DOUBLING MONEY IN THIS FAMOUS CANCER BIOTECH WITH APPLE CONNECTION, WHAT IS NEXT? $AAAP $AAPL $NEOS $NVS $PDLI $GILD $JUNO $ZIOP $BLCM $BLUE

Not long ago, French pharmaceutical company Advanced Accelerator Applications got a lot of publicity. Now it’s getting bought out.

The late Apple AAPL, co-founder Steve Jobs died from pancreatic cancer, specifically from a neuroendocrine tumor, or islet cell carcinoma. Advanced Accelerator Applications AAAP,  became famous because of its work on this type of cancer.

Please click here for an annotated chart of Advanced Accelerator Applications. For the sake of transparency, this chart is exactly the same as the one published on MarketWatch in March 2017 containing my call to buy this stock. Please see “Biotech firm says it’s closing in on the cancer that killed Steve Jobs.”

Arora Report subscribers have doubled their money as Novartis NVS,  is now buying this company for $82 a share in cash. This is the 130th buyout of an Arora Report portfolio company. Buyouts are lucrative for investors. It is too late for those not in this stock to get in, but the question is, which company is the next buyout candidate.

The Arora Report recently took a position in Neos Therapeutics NEOS,  a pharma company, not a biotech. It’s in the business of manufacturing and commercializing extended-release products using its proprietary technology.

Previously, Neos rejected a $10.25-a-share buyout offer from PDL BioPharma PDLI.  Now there is a report that the Grand Prairie, Texas-based company, whose market value is $289 million, has hired an investment banker to explore its alternatives. ..Read more at MarketWatch

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER